Al. [14] recently showed that usage of LF-LAM for hospitalized patients with low CD4+ cell count in South Africa was considered highly cost-effective compared with smearmicroscopy alone. The cost-effectiveness of incorporating LF-LAM testing as part of diagnostic algorithms with or without Xpert for a broader population of HIV-infected individuals, including outpatients and those with less immunos